We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
신규 편입 · 포트폴리오 비중 0.05%
신규 편입 · 포트폴리오 비중 0.00%
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $19.18 · 11 analysts
Stored first · Google News · Yahoo Finance (English)
BBNX Maintained by Goldman Sachs -- Price Target Raised to $19.0 - GuruFocus
BBNX Maintained by Goldman Sachs -- Price Target Raised to $19.0 GuruFocus
Goldman Sachs Maintains Beta Bionics(BBNX.US) With Buy Rating, Raises Target Price to $19 - Moomoo
Goldman Sachs Maintains Beta Bionics(BBNX.US) With Buy Rating, Raises Target Price to $19 Moomoo
Truist Raises Price Target on Beta Bionics to $22 From $18, Keeps Buy Rating - Moomoo
Truist Raises Price Target on Beta Bionics to $22 From $18, Keeps Buy Rating Moomoo
Truist Raises Price Target on Beta Bionics to $22 From $18, Keeps Buy Rating
ETFs Investing in Beta Bionics, Inc. Stocks - TradingView
ETFs Investing in Beta Bionics, Inc. Stocks TradingView
Enterprise value to EBIT forward of Beta Bionics, Inc. – NASDAQ:BBNX - TradingView
Enterprise value to EBIT forward of Beta Bionics, Inc. – NASDAQ:BBNX TradingView
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 07. 21. | After market close (AMC) | $-0.55 | — | — | $31.55M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $-0.93 | — | — | $17.64M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-5.86 | — | — | $44.68M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-4.44 | — | — | $27.98M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 28. | Goldman Sachs | — | Maintain | Buy → Buy | — | Goldman Sachs: Buy |
| 2026. 05. 19. | B of A Securities | — | Maintain | Neutral → Neutral | — | B of A Securities: Neutral |
| 2026. 04. 22. | Leerink Partners | — | Maintain | Outperform → Outperform | — | Leerink Partners: Outperform |
| 2026. 04. 22. | Stifel | — | Maintain | Buy → Buy | — | Stifel: Buy |
| 2026. 04. 15. | Truist Securities | — | Maintain | Buy → Buy | — | Truist Securities: Buy |
| 2026. 04. 10. | Goldman Sachs | — | Maintain | Buy → Buy | — | Goldman Sachs: Buy |
As of FY2026Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 987,351 | $30.08M | 0.05% | — | New position |
| 2 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 2,525,040 | $25.3M | 0.05% | — | New position |
| 3 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 410,603 | $12.51M | 0.02% | — | New position |
| 4 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 65,495 | $656.26K | 0.00% | — | New position |